Qube Research & Technologies LTD Agios Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 24,830 shares of AGIO stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,830

Previous 43,244 42.58%

Holding current value

$1.18 Million

Previous $1.26 Million 15.35%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $507,305 - $899,155	-18,414 Reduced 42.58%	24,830 $1.07 Million
Q1 2024 May 14, 2024	SELL	$21.32 - $34.81 $1.58 Million - $2.59 Million	-74,268 Reduced 63.2%	43,244 $1.26 Million
Q4 2023 Feb 13, 2024	BUY	$19.97 - $24.53 $2.35 Million - $2.88 Million	117,512 New	117,512 $2.62 Million
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $969,103 - $1.23 Million	39,061 New	39,061 $1.1 Million
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $841,655 - $1.55 Million	49,335 Added 139.11%	84,801 $1.88 Million
Q1 2022 May 09, 2022	BUY	$26.68 - $34.81 $32,683 - $42,642	1,225 Added 3.58%	35,466 $1.03 Million
Q4 2021 Feb 01, 2022	BUY	$29.58 - $49.78 $1.01 Million - $1.7 Million	34,241 New	34,241 $1.13 Million
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $577,355 - $809,097	-17,385 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$33.87 - $55.93 $588,829 - $972,343	17,385 New	17,385 $608,000
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $448,160 - $695,721	-13,009 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $410,043 - $700,014	13,009 New	13,009 $462,000

Others Institutions Holding AGIO

# of Institutions

226

Shares Held

56.3M

Call Options Held

275K

Put Options Held

251K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.6B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Agios Pharmaceuticals, Inc. Transaction History